MYGNMyriad Genetics, Inc.
$4.18-45% 1Y
$4.18
$2.8752 weeks$8.18
Is the price fair?
Watch
1 to watch, 2 without dataAt the top of its own P/E range. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
Vs its own P/E rangedearest in 12 quartersderived
Expensive vs its own history: P/E 107.1 vs a 23.6 median over 12 quarters (+353% vs median).
Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.
Diagnostics & Research
Ranks #17 of 21 by RyuScore